English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17431/19726 (88%)
Visitors : 6246939      Online Users : 736
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32664


    標題: Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
    作者: Lin, Jen-Tai
    Chan, Ti-Chun
    Li, Chien-Feng
    Huan, Steven K. H.
    Yu-Feng Tian(田宇峯)
    Liang, Peir-In
    Pan, Cheng-Tang
    Shiue, Yow-Ling
    貢獻者: Kaohsiung Vet Gen Hosp, Dept Surg, Div Urol
    Natl Sun Yat Sen Univ, Inst Biomed Sci
    Chi Mei Med Ctr, Dept Med Res
    Chi Mei Med Ctr, Dept Pathol
    Southern Taiwan Univ Sci & Technol, Dept Biotechnol
    Natl Hlth Res Inst, Natl Inst Canc Res
    Kaohsiung Med Univ, Inst Clin Med
    Chi Mei Med Ctr, Dept Surg, Div Colorectal Surg
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    Kaohsiung Med Univ Hosp, Dept Pathol
    Natl Sun Yat Sen Univ, Inst Med Sci & Technol
    Natl Sun Yat Sen Univ, Dept Mech & Electromech Engn
    關鍵字: urothelial carcinoma
    prognosis
    日期: 2019-04
    上傳時間: 2020-07-29 13:54:20 (UTC+8)
    出版者: WILEY
    摘要: The objective of this study was to examine the expression level of cytochrome P450 4B1 (CYP4B1) protein and its clinical significance in specimens from patients with urothelial carcinomas (UC) including upper tract urothelial carcinoma (UTUC, n = 340) and urinary bladder urothelial carcinoma (UBUC, n = 295). Data mining on public domains identified five potential candidate transcripts which were downregulated in advanced UBUCs, indicating that it might implicate in UC progression. Immunohistochemistry was performed to analyze the CYP4B1 protein levels on 635 tissues from UC patients retrospectively. Immunoexpression of CYP4B1 was further estimated using the H-score method. Correlations between CYP4B1 H-score and important clinicopathological factors, as well as the significance of CYP4B1 expression level for disease-specific and metastasis-free survivals were evaluated. In UTUCs and UBUCs, 118 (34.7%) and 92 (31.2%) patients, respectively, were identified to be of CYP4B1 downregulation. The CYP4B1 expression level was found to be associated with several clinicopathological factors and patient survivals. Downregulation of CYP4B1 protein was correlated to advanced primary tumor (p < 0.001), nodal metastasis (p < 0.001), high histological grade (p = 0.001), vascular invasion (p < 0.001), perineural invasion (p = 0.017) and mitotic rate (p = 0.036) in UTUCs and/or UBUCs. Low CYP4B1 protein level independently predicted inferior disease-specific (p = 0.009; p < 0.001) and metastasis-free (p = 0.035; p < 0.001) survivals in UTUC and UBUC patients. Our findings showed that downregulation of CYP4B1 protein level is an independent unfavorable prognosticator. Loss of the CYP4B1 gene expression may play an important role in UC progression.
    關聯: Apmis, v.127, n.4, pp.170-180
    Appears in Collections:[保健營養系(所) ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML29View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback